You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Respiratory conditions
  5. Respiratory infections

Isavuconazol for treating invasive aspergillosis or mucormycosis in people 1 to 17 years [TSID12284]

  • Topic prioritisation
  • Project information
  • Project documents

27352-Isavuconazole-for-Paediatric-Aspergillosis-or-Mucormycosis-V1.0-SEPT2025-NON-CONF.pdf

Back to top